Search for Clinical Trial Results

Sponsored By

Childhood Acute Lymphoblastic Leukemia - 25 Studies Found

Status Study
Active, not recruiting Study Name: Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008
Condition: Childhood Acute Lymphoblastic Leukemia
Date: 2013-09-26
Interventions:
  • Drug: PEG-L-asparaginase ind 1
Terminated Study Name: Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
Condition: B-Cell Pediatric ALL
Date: 2014-08-21
Interventions: Drug: Moxetumomab Pasudotox Participants received 6 doses of moxetumomab pasudotox 40 microgram per kilo
Recruiting Study Name: Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol
Condition: Lymphoblastic Leukemia, Acute, Childhood
Date: 2017-01-09
Interventions:
  • Drug: Allopurinol Allopurinol

Recruiting Study Name: Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Condition: Childhood Acute Lymphoblastic Leukemia in Remission
Date: 2012-01-03
Interventions:
  • Behavioral: behavioral intervention

Terminated Study Name: Treatment of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Date: 2005-09-09
Interventions:
  • Drug: asparaginase (E. Coli)
  • Drug: asparag
Completed Study Name: Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL
Condition: Lymphoblastic Leukemia, Acute, Childhood
Date: 2013-07-08
Completed Study Name: A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Condition: Lymphoblastic Leukemia, Acute, Childhood
Date: 2009-10-05
Interventions: Drug: Clofarabine incorporated into a 5-drug regimen Clofarabine (IV) 40mg/m2 into an intensive chemothe
Completed Study Name: Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
Condition: Recurrent Childhood Acute Lymphoblastic Leukemia
Date: 2004-12-08
Interventions:
  • Drug: L-asparaginase Given IM
Completed Study Name: Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
Condition: Recurrent Childhood Acute Lymphoblastic Leukemia
Date: 2004-08-04
Interventions:
  • Biological: alemtuzumab Given

Completed Study Name: Genomic Changes in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Date: 2010-03-17
Next >>>